Brief: Natco Pharma Says Board Approves Evaluation Of Agro Business Demerger
25/09/2025 06:31
Sept 25 (Reuters) - Natco Pharma Ltd NATP.NS: BOARD APPROVES EVALUATION OF AGRO BUSINESS DEMERGER COMPANY MAY RETAIN A SMALL MINORITY STAKE IN RESULTING COMPANY Source text: ID:nBSE7z0skr Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees